NANODEM
NANOphotonic DEvice for Multiple therapeutic drug monitoring
| Coordinatore | CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Via Madonna del Piano 10 contact info |
| Nazionalità Coordinatore | Italy [IT] |
| Totale costo | 5˙285˙964 € |
| EC contributo | 3˙983˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2011-8 |
| Funding Scheme | CP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-10-01 - 2016-09-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Via Madonna del Piano 10 contact info |
IT (Sesto Fiorentino-Firenze) | coordinator | 0.00 |
| 2 |
DATAMED SRL
Organization address
address: VIA PAPA GIOVANNI XXIII contact info |
IT (RODANO (MI)) | participant | 0.00 |
| 3 |
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Organization address
address: GESCHWISTER-SCHOLL-PLATZ contact info |
DE (TUEBINGEN) | participant | 0.00 |
| 4 |
INESC MICROSISTEMAS E NANOTECNOLGIAS-INSTITUTO DE ENGENHARIA DE SISTEMAS DE COMPUTADORES PARA OS MICROSISTEMAS E AS NANOTECNOLOGIAS
Organization address
address: Rua Alves Redol contact info |
PT (LISBOA) | participant | 0.00 |
| 5 |
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Organization address
address: ISMANINGER STRASSE contact info |
DE (MUENCHEN) | participant | 0.00 |
| 6 |
MICROFLUIDIC CHIPSHOP GMBH
Organization address
address: STOCKHOLMER STRASSE contact info |
DE (JENA) | participant | 0.00 |
| 7 |
Probe Scientific Ltd
Organization address
address: Sir Williams Lyons Road contact info |
UK (Coventry) | participant | 0.00 |
| 8 |
UNIVERSIDAD COMPLUTENSE DE MADRID
Organization address
address: AVENIDA SENECA 2 EDIFICIO SENECA contact info |
ES (MADRID) | participant | 0.00 |
| 9 |
UNIVERSITAET STUTTGART
Organization address
address: Keplerstrasse contact info |
DE (STUTTGART) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Project aim is the development of a novel therapeutic drug monitoring point-of-care-testing (POCT) device for the measurement of immunosuppressants and related metabolites in transplanted patients. The new device will allow the automatic measurements of therapeutic drugs and metabolites characterized by a narrow therapeutic range and serious potential side effects. Clinical benefit will be an optimized dosage of the respective therapeutical drug. The patient will be connected to the device by an intravenous microdialysis catheter to allow 48-h online measurements. Based on this minimally-invasive approach, the therapeutic drugs and related metabolites will be monitored at short time intervals. The need of mixing the dialysate with the chemical reagents and the necessity of incubation times for the bioassay implementation, unavoidable procedure for bioanalyte detection, implies that a continuous measurement of such analytes is impossible, but the miniaturisation down to micro- and nano-scales will lead to very short time intervals, of the order of a few minutes. Heart of the device will be a multi-parametric optical chip, which will make use of the recent developments in nanotechnology to convert the concentration changes of the analytes in detectable luminescent signals. Essential sections of the device will be also:ni) the microfluidic circuit before the chip, where the dialysate is mixed with the reagents necessary for the implementation of the biological assay;nii) the optical detection system which must be characterised by high efficiency and strong compactness;niii) the compact hardware control unit and user interface that allow instrument control and data handling.nThe integration of all these sections within the POCT stand-alone device requires the convergence of competences ranging from chemistry and biochemistry to optics and medicine as well as the convergence of micro and nanotechnologies, such as micro/nanofluidics,microdialysis and micro/nanosensing.